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Abstract.  The rates of internalization and uncoating of 
32p-labelled  human immunodeficiency virus (HIV)  in 
the human T  lymphoid cell line CEM are consonant 
with a  receptor-mediated endocytosis mechanism of 
entry. This interpretation was affirmed by electron mi- 
croscopic observation of virions within endosomes. 
Virus binding and infectivity were inhibited to the 
same extent by pretreatment with OKT4A antibody, 
therefore, the CD4 receptor-dependent pathway of in- 
ternalization appears to be the infectious route of en- 
try. The pattern of internalization by the human 
monoblastoid cell line U937 proved to be more com- 
plex,  involving rapid and efficient CD4-independent 
internalization. Electron microscopy revealed the pres- 
ence of large intracellular vesicles, each containing 
several virions. Antibody against the CD4 receptor for 
virus efficiently blocked infection, but did not reduce 
significantly HIV binding or internalization in the 
U937 cell line. Consequently, U937  cells have a CD4- 
independent pathway of virus internalization that does 
not coincide with the route of entry for infectious HIV. 
T 
HE  human  immunodeficiency virus  (HIV) t  infects 
primarily T cells of the helper/inducer class (17) and 
monocytes (6, 13, 24). To a large extent, this viral tro- 
pism is determined by the presence of the CD4 surface anti- 
gen on susceptible cells (5,  17, 20). The envelope glycopro- 
tein of HIV (gpl20) forms a noncovalent complex with the 
CD4  molecule and it is this reaction that determines the 
mechanism for HIV attachment to cells (19). Virus attach- 
ment is specific; the OKT4A monoclonal antibody binds the 
CD4 molecule and also blocks virus attachment and infec- 
tivity (14). 
Subsequent to the attachment step,  all enveloped viruses 
require fusion between viral and cellular membranes for in- 
sertion of their genome into host cells. For paramyxoviruses 
such as Sendai, measles, and respiratory syncytial virus (re- 
viewed in reference 21) fusion takes place at the plasma mem- 
brane and is mediated by a  specific viral peptide.  Among 
other enveloped viruses, most enter the cell via endocytosis 
and fusion occurs between the viral and endosomal mem- 
branes once the vesicle has been internalized. The latter pro- 
cess is designated receptor-mediated endocytosis and consti- 
tutes the route of entry for murine retroviruses (2). 
The unique chemical environment of the endosome facili- 
tates the uncoating reaction.  Shortly after internalization, 
endosomes become acidified (11, 22).  Under these acidic 
conditions, the virus membrane fuses with the endosomal 
membrane. Acidic conditions initiate membrane fusion and 
also promote disaggregation of  the nucleoprotein core during 
1.  Abbreviation used in this paper:  HIV, human immunodeficiency virus. 
influenza virus infection (reviewed in reference 21). Other 
distinctive features of the endosome can also promote un- 
coating of viruses. The elegant studies of  White and Helenius 
(33) demonstrate that endosomal membranes are specifically 
enriched in cholesterol and this provides the required target 
for Semliki Forest virus (SFV)  fusion and uncoating. In- 
terestingly enough, the envelopes of both HIV and SFV are 
enriched in cholesterol (1, 33).  The fusion reaction between 
viral and endosomal membranes is complex and may well re- 
quire low pH, unusual membrane lipid composition, or even 
both of these features. 
Formation of syncytia among infected cells is still another 
consequence of viral protein involvement in membrane fu- 
sion reactions.  In the case of HIV,  polykaryon formation 
among infected T cells is the most evident in vitro cytopathic 
effect (18) although this reaction has not yet been shown to 
be a significant factor in vivo. Polykaryon formation does not 
indicate a priori the mode of virus entry even though cell fu- 
sion occurs at neutral pH and is initiated by the presence of 
a viral protein in the cell membrane. Sendai virus, known to 
enter cells by direct membrane fusion, can be inactivated, 
then added to cell cultures, and polykaryons will form none- 
theless (26).  Vesicular  stomatitis virus (VSV),  on the other 
hand, gains entry into cells by receptor-mediated endocyto- 
sis yet is still able to induce syncytium formation among in- 
fected cells (4,  25).  As regards VSV, cell fusion occurs 4- 
12-h postinfection, but does not occur with inactivated virus 
(34) and, moreover, requires protein synthesis in the infected 
cell (25).  Consequently, polykaryon formation per se, is not 
a dependable indicator of the mode for virus entry. 
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lymphoid  (CEM)  and monoblastoid  (U937) cells.  The ki- 
netics of entry and uncoating of radiolabeled virus prove to 
be consonant with receptor-mediated endocytosis being the 
predominant mode of penetration rather than virus entry via 
plasma membrane fusion. This conclusion is affirmed by ex- 
tensive electron microscopic observation of the frequency of 
virions  within  endosomal  vesicles. No  evidence  was ob- 
tained that would lend support to the notion of direct fusion 
between the viral and plasma membranes. 
Materials and Methods 
Cell and Virus Strains 
CEM, a human T lymphoid cell line and U937, a human monoblastoid cell 
line derived from a histiocytic leukemia (31),  were used in these studies. 
The LAV1-A strain of HIV,  provided by  Dr.  D.  Richman (University of 
California,  San Diego),  was used in all of these experiments. 
Preparation of HIV Stocks 
Cultures of CEM cells growing logarithmically in RPMI-1640 medium plus 
10% heat-inactivated FBS, were infected with 0.2 TCIDso/cell and then in- 
cubated at  37°C in 5%  CO2.  The volume of the culture was doubled at 
2.5-d postinfection by the addition of fresh medium. At 5-d postinfection, 
cells and debris were removed by centrifugation. Virus was precipitated 
from the clarified supernatant by the addition of polyethylene glycol-8000 
to a  final concentration of 10%  (28).  The virus pellet was resuspended in 
0.01 of the original culture volume. Concentrated preparations had titers 
ranging from 5  ×  106 to  I  ×  107 TCID~0/ml;  infectivity was determined 
by measuring the cytopathic effect on MT-2 ceils (10).  Virus stocks were 
stored at -70°C. The reverse transcriptase activity of infected cell superna- 
tants was determined by  the  method of Popovic  et  al.  (28)  with  minor 
modifications. 
Preparation  of JZP-labeled Virus 
Infected cultures were prepared as described. At 3-d postinfection the cells 
were  recovered  by centrifugation, and then washed, and  resuspended in 
DME medium lacking phosphate (Gibco Laboratories, Grand Island, NY). 
Dialyzed  FBS  was added  to  a  final  concentration of  10%.  Carrier-free 
H33-~PO4 (New England Nuclear, Boston, MA) was added to a concentra- 
tion of I mCi/ml of culture; the cell concentration at the time of labeling 
was 5  x  10S/ml and ,'~80% of the cells stained positively in an indirect im- 
munofluorescence assay for detection of cell-associated viral proteins (not 
shown). 5 h after the addition of label, the cells were removed by centrifuga- 
tion. Supernatant virus was concentrated by centrifugation for 2 h at 18,000 
rpm, 4°C  in a  centrifuge (model J2-21;  Beckman Instruments Inc.,  Palo 
Alto, CA). The pellet was resuspended in 1 ml of NET buffer (16) containing 
22 % sucrose. The sample was layered atop a sucrose step gradient in which 
the upper phase was 22 % and the lower phase 50% sucrose (16). After 16 h 
of centrifugation at  16,500 rpm, the purified virus was collected from the 
interface between the two sucrose solutions. 
Characterization  of  Labeled Virus Preparations 
The labeled virus preparations were characterized four separate ways to de- 
termine the percentage of radioactivity present as high molecular weight 
RNA.  In the initial  characterization, the material displayed the expected 
sedimentation characteristics in the sucrose gradient.  Second,  all  of the 
counts could be pelleted by centrifugation through buffer at 18,000 rpm for 
12 h. Third, the counts could be immunoprecipitated specifically with anti- 
body  from  HIV-infected  individuals.  Fourth,  85-90%  of the counts re- 
mained TCA-precipitable after treatment at 37°C for  1 h  with 25  I~g/ml 
RNaseA. Approximately 90%  of the incorporated  radioactivity was ren- 
dered TCA-soluble when the virions were disrupted with 0.25% NP-40 be- 
fore a l-h incubation in the presence of 25 I.tg/ml of RNaseA. Consequently, 
90% of the up counts were susceptible to nucleolytic degradation in dis- 
rupted virions; this property is consistent with identification of the labeled 
material as high molecular weight viral RNA. These characteristics were 
virtually identical in three individual preparations of labeled virus. 
Measurement of Virus Binding 
In all virus-binding experiments, and in the subsequent determinations of 
virus uptake and uncoating, mild sonication disrupted viral aggregates be- 
fore their addition to cell cultures.  Dilutions of labeled virus were then 
added to tubes containing 2  x  103 cells in 1 ml of medium; the cells were 
cooled to 4°C for 10 min before the addition of virus. The mixtures were 
then incubated for  1 h at 4°C.  Unbound virus particles were removed by 
spinning the cells through a 0.5-ml cushion of undiluted bovine serum. Fur- 
ther washing did not decrease the number of counts significantly, thus a sin- 
gle wash was deemed adequate.  The virus was inactivated by heating to 
65°C for 1 h. Cerenkov radiation was determined by scintillation counting. 
Determination of the Kinetics for Virus 
Uptake and Uncoating 
For each time interval in the kinetic experiments, 15,000 cpm of virus were 
added to 7.5  ×  lO  6 cells in 3 ml of medium. The cells were cooled to 4°C 
before adding the virus; the mixtures were then incubated at 4°C for 15 rain. 
Finally, each sample was divided into three  1-ml aliquots that were pro- 
cessed in parallel. 
After preincubation at 4°C, the samples were warmed to 37°C for as long 
as 90 min.  At the appropriate  intervals, cells were  washed by spinning 
through a  l-ml cushion of bovine serum to remove the unbound counts; they 
were then resuspended in I ml of RPMI-1640 (without serum). A 0.25-ml 
sample was removed, inactivated, and set aside for determination of total 
cell-associated counts. 
Then, 0.25 ml of 0.25% trypsin solution were added to each of the re- 
maining 0.75 ml aliquots; the samples remained at room temperature for 
5 min. Viral particles bound to the surface of cells were released by the tryp- 
sin treatment and by again spinning the sample through a l-ml serum cush- 
ion, a wash that prevented further enzymatic action of trypsin. The resulting 
cell pellets were suspended in 0.75 ml of medium plus 10% serum, 0.25-ml 
aliquots removed, and added to 1.0 ml of cold 10% TCA; these samples rep- 
resent the internalized counts. The remaining cells in suspension  were lysed 
by two cycles of freeze/thawing, alternating between dry ice/ethanol and 
37°C water bath. A 0.25-ml aliquot was removed and added to  1.0 ml of 
cold  10%  TCA; this treatment yielded the coated plus uncoated counts. 
Repeated freeze/thawing did not alter the ratio of internalized to coated plus 
uncoated counts. The term coated plus uncoated has been introduced to ac- 
count for the differences between this and the internalized counts value. 
Since this difference is not an artifact of sample preparation, we must as- 
sume that the internalized counts contain a portion of material that becomes 
"I~A soluble subsequent to cell lysis. Accordingly, we presume that internal- 
ized, degraded RNA was precipitated when whole cells were added to TCA; 
when lysed cells were added these degraded counts became TCA soluble. 
The coated plus uncoated value refers to that portion of in~rnalized counts 
present  as  macromolecular  RNA.  To  the  remaining  0.25-ml  fraction, 
RNaseA was added to a final concentration of 25 ILtg/ml  and the mixture was 
incubated at 37°C for 30 min.  1.0 ml of cold  10%  TCA was then added. 
Table I. The Influence of  Multiplicity of  Infection on 
Virus Release by U937 and CEM Cells 
Reverse transcriptase activity~: 
Cell line  moi*  Day  I  Day 4  Day 4+OKT4A§ 
U937  0.2  2,350  +  125  6,375  +  360  1,592  +  205 
U937  1.0  3,235  +  76  10,060  +  283  ND 
U937  10.0  8,065  +  160  20,430  +  455  ND 
CEM  0.2  2,573  +  65  12,570  +  465  4,395  +  185 
CEM  1.0  3,860  +  115  22,681  +  1,050  ND 
CEM  10.0  8,145  +  263  49,850  +  2,230  ND 
Increments of 4  ×  10 cells/ml were  infected  for  2  h  at  37°C,  were  then 
washed, and resuspended in fresh medium. Aliquots of the culture were re- 
moved on days I and 4, cleared of cells by centrifugation, and the reverse tran- 
scriptase activity present in the cell-free supernatant determined. 
* Multiplicity  of infection  represents the TCID/5o of HIV per cell. 
:~ Reverse transcriptase activity  is the cpm of ~2P-dTTP incorporated  in 2 h 
at 37°C. 
OKT4A antibody was added to cell cultures, at 5 p_g/ml, 2 h prior to virus 
challenge. 
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covered  by  centrifugation  in  a  Eppendorf microfuge (Brinkman Instru- 
ments, Inc., Westbury, NY) for 2.5 min. The pellets were rinsed with 70% 
ethanol, dried, and Cerenkov radiation was measured by scintillation count- 
ing. The triplicate determinations were averaged and recorded as single data 
points, standard errors did not exceed 15% of the mean. 
Electron Microscopic Analysis of  lnfected Cells 
Cells in suspension at 4°C were  infected with  ",,30  TCIDs0/cell and the 
mixture kept at this temperature for  15 rain. The value of 30 TCIDs0/cell 
was selected to provide ,'~10,000 virus particles for each cell in the suspen- 
sion (2). After the preincubation at 4°C, infected cultures were warmed to 
37°C for intervals ranging from 2.5 to 60 min; the cells were then concen- 
trated by centrifugation and resuspended in cold PBS. Immediately there- 
after the cells were fixed by glutaraldehyde and osmium tetroxide (12), de- 
hydrated,  embedded  in  epoxy  resin,  sectioned  and  then  stained  with 
saturated methanolic uranyl acetate and lead citrate before electron micros- 
copy.  Micrographs were  recorded  in a  Philips  300 electron microscope 
equipped with an eucentric goniometer stage. The microscope was operated 
at 80 kV with a  50 lam objective aperture. 
Results 
CEM and U937 Cells are Permissive  for 
HIV Replication 
The laboratory stocks of the LAV1-A isolate of HIV were 
effective in establishing productive infection in the T  lym- 
phoid cell line CEM and the monoblastoid line U937. These 
results are consistent with previous observations and con- 
firm that our cell lines were susceptible and our virus prepa- 
rations were infectious. Table I  delineates the relationship 
between multiplicity of infection and the yield of newly syn- 
thesized virus on d-1 and -4 postinfection. Cells were also 
pretreated with the OKT4A antibody (provided by Dr. Gideon 
Goldstein, Ortho Pharmaceuticals, Raritan, NJ) and then in- 
fected at low multiplicity.  This antibody pretreatrnent re- 
duced substantially the level of virus released and indicated 
that productive infection of CEM and U937 cells requires in- 
teraction between HIV and the CD4 molecule. These experi- 
ments were performed routinely at an antibody concentra- 
tion of 5  ~tg/ml.  Complete (>95%) inhibition of infection 
was obtained at antibody concentrations of 1>10 lxg/ml; the 
former conditions were used to conserve OKT4A material. 
At a multiplicity of infection of 1 TCIDs0/cell, "~85 % of the 
CEM cells in culture, and 70% of the U937 cells on d-3 post- 
infection, reacted positively with antibody directed against 
the viral p24 protein (not shown). 
Binding of  Radiolabeled Virus to CEM and U937 Cells 
The binding of radiolabeled HIV to two susceptible cell lines 
was assayed in an experiment that served as the baseline for 
further characterization of the labeled virus preparations and 
selection of conditions for optimal binding of HIV to cells. 
The capacity for OKT4A antibody to block virus binding was 
also assessed. 
Results  of four independent binding  experiments (using 
two independent virus preparations) are shown in Fig. 1. The 
binding data are presented in the form of a Scatchard plot so 
that the relative affinity constants may be perceived more 
clearly. The T cell line, CEM, has a rather typical binding 
profile for radiolabeled HIV; at low virus concentrations, a 
steep curve with negative slope indicates that the radiola- 
beled material binds to cells with high affinity. At higher vi- 
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Figure 1.  Scatchard plot of 32P-HIV binding to CEM  vs.  U937 
cells. Solid circles represent the data for CEM cells; solid squares 
identify the data for U937 cells. The open symbols refer to the effect 
of pretreatment of CEM and U937 cells with the OKT4A antibody 
prior to addition of virus. Vertical bars denote the standard errors. 
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rus concentrations, the more flattened curve is indicative of 
low affinity binding. High affinity binding between the virus 
and the CD4 molecule on the cell surface had been antici- 
pated, but the low affÉnity binding might be attributed to the 
presence of broken or degraded virions in the preparation, 
or to dissociation of some virions after binding to the cell 
surface, or perhaps even the presence of a second class of 
lower affinity binding sites. 
A different binding profile was  found for the U937 cells. 
Here no steep curve of negative slope was observed even at 
very low virus concentrations. The low affinity binding curve 
was similar to that observed for the T cell lines. However it 
is possible that the lack of high affinity virus receptors on the 
U937 cells may be more a reflection of the limit of this ex- 
perimental tool. High affinity receptors might well have been 
detectable had the radiolabeled virus preparations been of 
higher specific activity. Accordingly, we conclude only that 
the U937 cells possess significantly smaller numbers of high 
affinity receptors than the T  cells. 
To determine the role of CD4 molecules in the binding 
reaction, aliquots of CEM and of U937  cells were prein- 
cubated with the OKT4A antibody and then interacted with 
radiolabeled  HIV.  The open  symbols  in  Fig.  1 show  the 
amount of virus binding to antibody-coated cells. Pretreat- 
ment with 5 ~tg/ml of antibody prevented ~75 % of the bind- 
ing of HIV to CEM cells; this value is consistent with the 
observed differences between high and low affinity receptors 
and shows that the high affinity binding was prevented by an- 
tibody. However, the same antibody blocked <20%  of the 
binding to U937 cells. These data indicate that most of the 
virus binding to T cells occurs via the CD4 surface molecule 
and is of high affinity, whereas the predominant binding event 
between HIV and U937 cells is of low affinity and does not 
involve the CD4 molecule. 
Kinetics of  HIV Uptake and Uncoating in CEM 
Versus U937 Cells 
The analysis of HIV penetration into susceptible cells was 
extended further by measuring the rates of virus internaliza- 
tion and  uncoating.  The assay  relied on the use of virus 
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Cell line 
CEM  CEM  U937  U937 
$cpm of J:P-labeled HIV/2.5  x  106 cells 
Time at 37°C 
$Cell-associated  virus 
~:Internalized, trypsin resistant, virus 
tCoated plus uncoated 
$Coated,  internalized virus (RNase resistant) 
5,000  5,000  5,000  5,000 
0  min  30 min  0  min  30  min 
2,850  ±  405  3,650  ±  521  1,270  ±  185  1,310  ±  176 
185  ±  24  2,072  ±  283  114  ±  27  1,061  ±  102 
150  ±  32  1,480  ±  211  89  ±  17  531  ±~ 
135  ±  27  962  ±  127  ~  ±  14  459  ±  47 
* The experimental method is detailed in the text. 
Counts per minute of cerenkov radiation. 
preparations in which the viral nucleic acid was the principal 
radiolabeled component. Indeed, the 32P-labeled HIV prep- 
arations yielded >90% virion counts in the RNA. As in the 
binding experiments, radiolabeled virus and cells were ad- 
mixed and incubated at 4°C for 15 min before use. Samples 
were  then  warmed  to  37°C  to  initiate  virus  uptake.  It is 
noteworthy that no uptake was measurable unless the cells 
had been warmed. At specific intervals subsequent to warm- 
ing, samples were removed and the distribution of radioac- 
tivity into four separate fractions determined. The total num- 
ber of bound counts was designated as cell-associated virus. 
Surface-bound viral particles were removed by trypsiniza- 
tion and the total number of counts remaining was labeled 
internalized virus. After the surface-bound counts had been 
removed  by  trypsin  treatment,  the  cells  were  lysed  by 
freeze/thawing  and  then,  to  discriminate  between  macro- 
molecular and degraded viral RNA,  the samples were pre- 
cipitated with cold TCA. The counts recovered at this point 
represent the total of coated plus uncoated virus. Finally, the 
uncoated virus RNA present in the cell extracts was degraded 
by RNaseA treatment and the residual counts were then re- 
covered by TCA precipitation;  this  fraction  contained  the 
coated virus. The amount of internalized, but degraded, viral 
material was calculated by subtracting the coated plus un- 
coated value from the internalized value. Analogously, the 
amount of uncoated virus was determined by subtracting the 
value for coated virus from the coated plus uncoated virus 
value. We have used freeze/thaw lysis in order to avoid proce- 
dures involving manual disruption of HIV-infected cells.  It 
must be noted that this procedure disrupts organelle struc- 
ture  thus  we  cannot  discriminate  between  uncoated  viral 
RNA released to the cytoplasmic matrix and that portion re- 
maining in the vesicle. We presume that the majority of un- 
coated,  macromolecular HIV RNA  is present in the cyto- 
plasm. 
An example of the results from three experiments is shown 
in  Table II. The samples that were not incubated at 37°C 
serve as baseline controls; the data demonstrate that trypsin 
treatment removed the surface-bound virus counts efficiently 
and no internalization was observed at low temperature. 
Fig. 2 illustrates the time course of virus uptake and its un- 
coating in CEM cells. The experiments were performed with 
virus concentrations that reflected high affinity binding (Fig. 
1); the data are a composite of eight individual experiments 
involving three different preparations of radiolabeled virus. 
Virus internalization proved to be a relatively slow and in- 
efficient process in the CEM cells. A maximum of 60%  of 
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Figure 2.  Internalization and uncoating of 3~P-HIV in CEM cells. 
Cells  and  32p-HIV were  admixed,  preincubated  at  4°C,  then 
warmed  to  37°C for  the  intervals  indicated.  Each  sample  was 
processed in triplicate; the data given reflect the average of these 
determinations  for eight individual experiments. The data are ex- 
pressed as percentage of cell-associated counts;  solid squares are 
the values for internalized virus,  solid triangles  represent coated 
plus  uncoated material and  solid circles  identify coated virions. 
Open  squares  show the  total  number  of cell-associated  counts 
throughout the time course. 
the total counts had been internalized after 30-rain incuba- 
tion at 37°C.  The differences between the curve representing 
internalized counts and that for coated plus uncoated counts 
were relatively small, indicating that little degradation of the 
internalized material had occurred. Virus uncoating, demon- 
strated by the difference between the coated plus uncoated 
and the coated curves,  was also slow but had reached ap- 
preciable levels within 30 min after warming to 37°C.  The 
latter two curves diverged significantly at longer intervals, 
indicating the presence of stable uncoated viral RNA.  The 
half-life of the uncoated viral RNA was calculated to be >1 h. 
The time course of HIV uptake and  uncoating  in  U937 
cells was significantly different from that for the T cell line 
(Fig.  3).  Here,  internalization of virus was rapid and effi- 
cient.  Approximately 90%  of the  cell-associated material 
had  been  internalized  within  5  min;  rapid  changes  in  the 
amounts  of uncoated  and  coated  virus  were perceived as 
well.  The differences between values  for internalized  and 
coated plus uncoated were substantial, indicating that the in- 
ternalized material was being degraded rapidly. At longer in- 
tervals, there was but little difference between the coated plus 
uncoated and coated values, thus the uncoated viral RNA ap- 
peared to be rather unstable. No accurate estimate of the half- 
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Figure 3. Internalization and uncoating of 32p-HIV in U937 cells. 
Symbols are the same as in Fig. 2 except that open symbols depict 
the percentage of cell-associated counts in the three compartments 
described in the previous legend and solid squares show the total 
cell-associated counts. 
life of the viral RNA was made; presumably this value was 
well under 15 min. 
The biochemical analysis of virus penetration had pro- 
vided  strong  evidence that  internalization  proceeded  via 
receptor-mediated endocytosis.  The case  was  particularly 
clear for CEM cells where RNase-resistant particles were 
accumulated in the cells; this phenomenon is incompatible 
with the notion of  direct membrane fusion as the mode of en- 
try. Similar particles were accumulated in the U937 cells, al- 
though the rates of uptake and uncoating were different from 
those observed in the T cell line. It is possible that a small 
percentage of bound virions penetrate the U937 cells in the 
same manner as observed for the T cell line. However, it was 
not feasible to measure these slower rates as they would have 
been obscured by the faster, dominant, mode of entry. Ac- 
cordingly, the biochemical data alone were inadequate to dis- 
criminate between these opposing possibilities.  Moreover, 
the conclusion that HIV entered the cells by receptor-medi- 
ated endocytosis had rested on a single, crucial, experimen- 
tal observation: RNase resistant particles were internalized. 
That the virus could have entered the cell by direct fusion 
with the plasma membrane and that the ribonucleoprotein 
core of the virus remained RNase resistant for some time 
thereafter remained a real possibility. It was to discern the 
structural basis for the disparate rates of uptake and uncoat- 
ing between the two cell lines, and especially to gain inde- 
pendent evidence concerning the mode of  virus entry that the 
time course analysis was repeated using electron microscopy 
as the preferred means of following directly the structure and 
distribution of infecting virus particles. 
Structural Analysis of  HIV Penetration 
The experimental design was similar to that used in the ear- 
lier biochemical analysis of virus entry; cells and virus were 
preincubated at 4°C and then warmed to 37°C for various 
intervals.  The cells  were  infected at  a  multiplicity of 30 
TCIDs0/cell  to yield ~10,000  virus particles per  cell.  In- 
fected cells were collected by centrifugation, resuspended in 
ice-cold saline, and then fixed with glutaraldehyde and os- 
mium tetroxide. Samples taken from each point in the kinetic 
experiments were sectioned, stained, and observed via elec- 
tron  microscopy.  Representative  specimens  were  photo- 
graphed and assembled into a  series displaying accurately 
the time course of events. 
The pathway of virus entry into the T cell line is clearly 
delineated in Fig. 4. It is evident that bound virions are en- 
closed in vesicles and then internalized. Fig. 4, A and B show 
the bound virus and a single particle within a fold on the cell 
surface; this appears to be the initial stage of vesicle forma- 
tion. Fig. 4, C and D reveal both surface-bound virions and 
intact virus particles enclosed entirely in intracellular vesi- 
cles; the vesicles appear to be endosomes. Fig. 4 E depicts 
a section in which most of the virus particles are within en- 
dosomes. Particles within endosomal vesicles are sometimes 
seen as having fused directly with the endosomal membrane 
as is evident in Fig. 4 F.  Internalized virions have slightly 
smaller  diameters  than  extracellular particles  and  lack  a 
clearly defined limiting membrane. The ribonucleoprotein 
core appears to be disorganized in internalized particles and 
is spherical as opposed to the characteristic cylindrical core 
structure of HIV.  In most cases, the virus particles appear 
to interact directly with the endosomal membrane; the area 
of contact between virus and endosomal membranes is gen- 
erally greater than the area of contact observed for particles 
bound to the exterior plasma membrane.  To provide addi- 
tional evidence in support of our contention that fusion oc- 
curs between the viral and endosomal membranes, we exam- 
ined other examples by tilting the  samples  in an  electron 
microscope equipped with a goniometer stage, and then pho- 
tographing the sample from three distinct angles; these data 
are shown in Fig. 5. Close interaction between viral and en- 
dosomal membranes was observed from all angles. The ex- 
amples shown in Fig. 5, and numerous other samples, appear 
to reveal fusion between the viral and endosomal membrane. 
The use of the tilting stage established that the close apposi- 
tion of viral particles and endosomal membranes was not an 
artifact of preparation or analysis,  however, it has not yet 
been possible to provide unequivocal evidence for continuity 
between viral and endosomal membranes. Accordingly, these 
data indicate that virus particle uncoating can occur in the 
endosome and  are  supportive of the  contention that  HIV 
penetration proceeds via receptor-mediated endocytosis. 
The appearance of intact viral particles within endosomes 
and the observation of structures consistent with direct fu- 
sion between the viral and vesicular membranes constitutes 
compelling evidence that viral particles do enter the cell via 
receptor-mediated endocytosis. It should be noted that, in the 
course of this study,  >2,000 surface-bound virus particles 
were examined. In no instance was there any indication of 
direct fusion with the surface plasma membrane. 
An explanation for the differences in rates of uptake and 
uncoating between the CEM and U937 cell lines was pro- 
vided by electron microscopic analysis. Occasionally, there 
were observed individual virions contained within vesicles 
similar to those seen in the CEM cells. However, the great 
majority of virus particles were contained within membrane- 
bounded vesicle structures; one example is shown in Fig. 6. 
Accordingly, it seems apparent that virus particles are gener- 
ally engulfed in phagocytic vesicles; inasmuch as phagocytic 
vesicles represent a  degradative compartment, this obser- 
vation could account for the enhanced rate of uptake and 
degradation of HIV in U937  cells. The majority of U937- 
internalized virus  particles  are  distinct  structurally  from 
CEM-internalized virus.  In U937 cells,  multiple,  well-de- 
Pauza and Price HIV Penetration of T Cells and Monocytes  963 Figure 4. Pathway of HIV entry into CEM cells. Mode of infection and specimen preparation are detailed in the text. The six panels depict 
the time course of virus penetration.  The time postinfection is: (A) 0, (B) 2.5,  (C) 5, (D) 7.5, (E)  10, and (F) 20 min. Virus particles 
are recognized as spheres with dense cores and are ~100 nm in diameter. These particles were never encountered in uninfected cells. Partic- 
ular attention is directed to the structure indicated in F; here, the virion membrane is fused to the endosomal membrane during uncoating 
of the virus particle. 
fined virions were observed in single vesicles and most of 
these particles do not appear to interact with the vesicular 
membrane.  The  particles  have  intact  limiting  membranes 
and well-defined ribonucleoprotein cores. 
In no instance were vesicles containing more than a single 
virion observed in CEM cells. Even though the route of virus 
penetration into U937 cells is more complex than for the T 
cell line, no evidence for direct fusion between the viral and 
plasma membranes was obtained; this despite examination of 
>1,000 virions bound to the surface of the U937 cells. 
Discussion 
The biochemical and electron microscopy analyses reported 
here strongly affirm that HIV enters the T  cell (line CEM) 
via receptor-mediated endocytosis and that the CD4 surface 
antigen  is  an  important  component  of the  viral  receptor. 
These conclusions derive from four experimental observa- 
tions: (a) virus binding and infectivity were inhibited to the 
same extent by OKT4A antibody pretreatment of CEM cells, 
(b) virus particles were internalized within endosomes,  (c) 
fusion  between  viral  and  endosomal  membranes was  ob- 
served, and (d)  fusion between the viral and plasma mem- 
branes was never observed. Accordingly, the dominant route 
of particle internalization into T cells is identical to the infec- 
tious route of entry and is believed to proceed in three stages: 
(a) binding of HIV to the CD4 surface receptor, (b) internali- 
zation of the receptor-virus complex, and (c) fusion between 
the viral and endosomal membranes. 
The pathway of virus penetration  into the monoblastoid 
cell line U937 is more complex than the situation in T cells. 
Internalization and degradation of HIV were very rapid in 
these cells, thus, we presume that this represents phagocyto- 
sis of virus as opposed to the slower rates of endocytic inter- 
nalization  observed  in  CEM  cells.  Pretreatment  of U937 
cells  with  CD4-blocking  antibody  does  not  inhibit  virus 
binding to any significant extent yet it efficiently prevents in- 
fection. Recall that only 20 % of virus binding was prevented 
by pretreatment of cells with 5 ~tg/ml of OKT4A monoclonal 
antibody and that ~90%  of the cell-associated counts were 
internalized  more  rapidly  than  in  CEM  cells;  these  two 
populations of cell surface-bound virions appear to be func- 
tionally distinct.  Accordingly, the infectious route of entry 
into  U937  cells does  not  appear to  parallel  the  dominant 
pathway for internalization of virus particles.  It is conceiv- 
able that  some viral particles  enter the  U937  cells by the 
slower pathway of receptor-mediated endocytosis but  thus 
The Journal of Cell Biology, Volume  107, 1988  964 Figure 5.  Tilt series on two additional examples of virion-endosome fusion. Specimens were placed on a goniometer stage and observed 
from  -205 0 °, or +20°C incident to the beam. In A-C, the upper vesicle contains a virus particle attached to the endosomal membrane 
and the lower vesicle demonstrates fusion between virion and endosomal membranes. Another example of close association between viral 
and endosomal membranes is shown  in D-F.  The tilt axis for all of these panels is along the 8 o'clock to 2 o'clock diameter. 
far,  it has not been feasible to measure these rates directly 
as they are obscured by the more rapid, phagocytic pathway. 
Although not yet demonstrated conclusively, it would seem 
likely that entry of infectious HIV into U937 cells occurs via 
receptor-mediated endocytosis and  that  the  CD4-indepen- 
dent phagocytic pathway  is noninfectious. 
The data presented here and the conclusions drawn stand 
in sharp contrast to those of Stein et al. (30) who reported 
that HIV penetration into the human T lymphoid cell line VB 
occurred  via  direct  fusion  between  the  viral  and  plasma 
membranes  and  that endosomes containing virus particles 
were never encountered. Three reservations to these conclu- 
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cell line. Numerous  virus particles  are evi- 
dent within a phagocytic vesicle. The lower 
portion shows a low magnification reproduc- 
tion of the same cell to provide perspective as 
regards the size of the vesicle relative to the 
size of the cell. 
sions can now be entered.  First,  the authors  reported that 
lysosomotropic agents failed to inhibit virus entry although 
significant inhibition of HIV provirus accumulation had been 
observed when the cells were pretreated with either chloro- 
quine or monesin. The decrease in proviral accumulation in 
the presence of chloroquine, was similar to the observed in- 
hibition of murine retrovirus infection in mouse fibroblasts 
(2);  in the murine experiments these data were interpreted 
in favor of receptor-mediated endocytosis.  Second,  experi- 
ments concerning the ability of HIV to promote polykaryon 
formation  do  not  constitute  very  compelling  evidence  as 
regards the route of entry. Indeed the inability of inactivated 
HIV to initiate syncytium formation is rather suggestive that 
cells must be infected, and express virus proteins de novo, 
for fusion to occur.  A  similar result has been obtained for 
VSV; VSV penetrates cells by receptor-mediated endocytosis 
and subsequent formation of syncytia then depends on pro- 
tein synthesis in the infected cells (34). Finally, the electron 
microscopic evidence presented by Stein (30) was insufficient 
to support a firm conclusion. Previous demonstrations of vi- 
ral penetration by membrane fusion (e.g., Fig. 10 in reference 
23) were based on unequivocal visual evidence for continuity 
between the viral and plasma membranes. Such direct con- 
nection between the viral and cellular membranes is not es- 
tablished by the single example presented in Stein et al. (30). 
It should also be noted that the experiments of Stein et al. 
(30) were performed with the VB cell line and the HTLV- 
IIIB viral strain whereas the data in the present report were 
obtained with CEM and  U937  cells and using the  LAV1-A 
strain  of HIV.  Although  it  seems  unlikely  that  the  virus 
would use different modes of entry into two different human 
T cell lines, this possibility is not excluded at present. Rather 
compelling evidence for HIV penetration by receptor-medi- 
ated endocytosis is presented here; these results are consis- 
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fact that the CD4 surface molecule is internalized upon lym- 
phocyte activation (32) or in consequence of binding a ligand, 
in this case monoclonal antibody (29),  provides additional 
evidence  supporting  receptor-mediated  endocytosis  as  the 
route of HIV penetration. 
The findings which emerge from this study encourage the 
view that antibody responses elicited via vaccination might, 
after all, be effective in protecting individuals against infec- 
tion. Studies on the uptake and uncoating of HIV in the U937 
cell line are consonant with the view that virus entering these 
cells via phagocytosis no longer is infectious. Accordingly, 
it  is  anticipated  that  antigen-antibody  complexes  can  be 
cleared from the circulation without deleterious effect on the 
host monocyte/macrophage population. It is possible that an- 
tibody-dependent enhancement of infectivity, as seen with 
Flaviviruses (7, 8), may occur in the HIV situation. However, 
antibody enhances the rate of visna virus uptake by sheep 
macrophages without increasing the rate of infection (16). 
The fact that HIV enters the cell via an endocytotic route 
also portends the likelihood of novel targets for vaccine de- 
velopment.  The studies of Gollins and Porterfield (9) have 
already revealed that it is possible to generate neutralizing 
antibody responses against the West Nile Virus, despite fail- 
ure of these antibodies to block virus binding. Presumably 
such antibody molecules  prevent the interactions between 
bound virus and a second site on the endosomal membrane 
where the uncoating process is initiated. In that event, vac- 
cines directed at this second site in the HIV-uncoating ma- 
chinery could well offer the further advantage of not inducing 
antibody responses  that interfere  with the CD4  molecule. 
This would be a favorable development as this lymphocyte 
surface entity has been shown to be intimately involved in the 
activation of T cells (15). 
In the course of our basic studies on the interactions be- 
tween human immunodeficiency virus and susceptible cells, 
several important features of the mechanism of virus pene- 
tration have been elucidated. It is most likely that the infec- 
tious route of entry for HIV  into T  cells  proceeds  via re- 
ceptor-mediated  endocytosis.  Consequently,  cells  become 
susceptible to HIV infection because the CD4 molecule is 
present at the cell surface and is being internalized actively. 
It will be important to determine whether the interaction be- 
tween HIV and the CD4 molecule can promote internaliza- 
tion or, as is the case for transferrin  receptor (3, 27), cycling 
to the interior is independent of ligand binding. It is likely 
that virus penetration into monocytes also occurs by the en- 
docytotic mechanism  despite  the fact  that phagocytosis of 
viral particles, which appears to be a noninfectious process, 
is dominant. Agents that inhibit virus penetration into T cells 
would thus be protective of monocytes as well. Accordingly, 
the present studies provide a  fresh experimental  model  to 
support development and testing of antiviral compounds that 
inhibit HIV penetration of suceptible cells. 
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